Concomitant medical products: fresenius kabi freeflex ; ecoflac plus 500ml bottle,iv bag/bottle, iv flush syringe, unknown manufacturer.Report source - ceo (b)(6).Requested patient demographics however customer declined to answer.Although requested, product has not been received.A follow up report will be submitted with failure investigation results should the product be received for evaluation.
|
It was reported that the rn initiated the clinical trial compound c1d1 infusion of 9-ing-41(103 mg/ 520 ml/0.2mg/ml/0.1-1mg/ml) routinely administered over 1hr using a 0.2 filter set.Approximately 30 mins.Into the infusion, the device alarmed for occlusion alarms, patient received 310ml of the total 520ml infusion.The rn flushed the line which was patent and received good blood return.The device was then restarted however the device continued with occlusion alarms.The filter tubing was disconnected after multiple techniques were attempted to fix the occlusion, including changing pump channel, adding 120cc air into collapsed bag and adjusting the connections.The bag and tubing were taken back to pharmacy and tubing was disconnected, wasting approximately 26ml of solution which was destroyed.A new 0.2 micron filter tubing was attached and primed with the trial compound solution.After restarting the infusion, approximately 154ml infused, the device alarmed for occlusion alarms, the infusion was stopped and the remaining unspecified volume was discarded.The event occurred in the oncology clinic.It was later reported that the customer switched to a 1.2 micron in-line filter for the clinical trial without any issues due to a larger filter.There was no report of patient harm.
|